Artículos por temáticas

The space-time continuum in neurological disorders of the autophagosome-lysosome fusion machinery

Dafsari HS, Schuler J, Schober E, Möller B, Antebi A, Fanto M, Jungbluth H.

Autophagy Rep. 2025 Oct 12;4(1):2560903. doi: 10.1080/27694127.2025.2560903. eCollection 2025.

From Topography to Therapy: Rethinking Cognitive Monitoring in GBA1-Linked Parkinson's Disease

Liu M.

Ann Neurol. 2025 Oct;98(4):899. doi: 10.1002/ana.70007. Epub 2025 Jul 29.

Cerium-based nanoparticles for neurodegeneration: emerging redox therapeutics beyond pharmaceuticals

Mishra K, Tripathi S, Tiwari AK, Rana R, Yadav P, Chourasia MK.

RSC Adv. 2025 Oct 9;15(45):37540-37569. doi: 10.1039/d5ra03599f. eCollection 2025 Oct 8.

Response to letter to Editor on "Circulating cell-free DNA as predictors of Parkinson's disease"

Møller SG.

Parkinsonism Relat Disord. 2025 Oct;139:108004. doi: 10.1016/j.parkreldis.2025.108004. Epub 2025 Aug 20.

Clinical Reasoning: A 58-Year-Old Man With Resting Tremor, Bradykinesia, and Distal Numbness

Costa R, Braz L, Pinto M, Soares C.

Neurology. 2025 Oct 21;105(8):e214183. doi: 10.1212/WNL.0000000000214183. Epub 2025 Sep 22.

Pisa syndrome partly responsive to immunotherapy in IgLON5 disease

Gupta S, Mehta S, Mishra S, Takkar A, Shree R, Lal V.

Clin Neurol Neurosurg. 2025 Oct;257:109118. doi: 10.1016/j.clineuro.2025.109118. Epub 2025 Aug 22.

Spontaneous remission of dropped head syndrome following short-term bed rest in acute encephalopathy: a case report

Yamada G.

Neurol Sci. 2025 Oct;46(10):5413-5416. doi: 10.1007/s10072-025-08313-5. Epub 2025 Jun 21.

The Digital Frontier in Huntington's Disease: Opportunities for Clinical Trials

Quinn L, Roché MW, Dorn J, Adams JL.

Mov Disord. 2025 Oct;40(10):2067-2076. doi: 10.1002/mds.30277. Epub 2025 Jul 14.

The usefulness of microbiome profiling for geriatric patients with neuropsychiatric conditions: a scoping review

Tanevska E, Leyton CE, Seamark R.

Transl Psychiatry. 2025 Oct 20;15(1):420. doi: 10.1038/s41398-025-03685-w.

An Insight into Long-Term Outcomes in a Parkinson's Disease Minor Phenomena Cohort

D'Souza L, Singhvi M, Bhat CSP, P B S, B R N.

Mov Disord Clin Pract. 2025 Oct;12(10):1686-1687. doi: 10.1002/mdc3.70212. Epub 2025 Jul 14.

Movement Disorders in Central Nervous System Tuberculosis: A Systematic Review

Garg RK, Pandey S, Mahdi RA, Singhal S.

Can J Neurol Sci. 2025 Sep 29:1-10. doi: 10.1017/cjn.2025.10436. Online ahead of print.

Exploring the Effectiveness of Immersive Virtual Reality Rehabilitation for Parkinson's Disease: A Narrative Review

Nartea R, Poenaru D, Constantinovici MI, Potcovaru CG, Cinteza D.

J Clin Med. 2025 Sep 28;14(19):6858. doi: 10.3390/jcm14196858.

Advancing nanotheranostics for neuro-immunological disorders: current status and future prospects

Rai S, Nair A, Saleem Z, Ray SK, Kanwar JR, Mukherjee S.

Neuroscience. 2025 Oct 15;585:233-248. doi: 10.1016/j.neuroscience.2025.08.051. Epub 2025 Sep 2.

Metabolic reprogramming in diabetes and other endocrine and metabolic disorders: exploring the Warburg effect, ketones, and SGLT2 inhibitors

Carrera-Bastos P, Muskiet MHA, Mata-Ordoñez F, Pruimboom L, Lucia A, Luque RM, Muskiet FAJ.

Rev Endocr Metab Disord. 2025 Oct 23. doi: 10.1007/s11154-025-09996-z. Online ahead of print.

Developing New Strategies to Construct Pseudo-natural Macrocycles for Undruggable Targets

Wang H, Bi T, Yang W.

Acc Chem Res. 2025 Oct 7;58(19):3096-3110. doi: 10.1021/acs.accounts.5c00524. Epub 2025 Sep 14.